• Archives of Pharmacal Research
• /
• 제19권6호
• /
• pp.475-479
• /
• 1996

Diethylcarbamazine (DEC, 1-diethylcarbamyl-4-methylpiperazine) is an antiparasitic piperazine derivative used in the treatment of lymphatic filariasis caused by Wuchereria bancrofti, Brugia malayi or grugia timori. DEC-N-oxide is a major metabolite in humans and has antifilarial activity. In carrying out pharmacokinetic studies, gas chromatographic analysis of DEC in plasma can be complicated by the presence of the metabolite, since the thermally unstable DEC-N-oxide is converted back to a material which coelutes with DEC under the conditions of the analysis. We now report a method to separate DEC-N-oxide from DEC in plasma using solid phase extraction with subsequent gas chromatographic analysis using a nitrogen specific detector. One-diethylcarbamyl-4-ethylpiperazine (E-DEC) was the internal standard. The standard curve of DEC was linear in the range of 10 to 200 ng/ml as described by Y=0.0350+0.0128X, $R^2=0.999$. The limit of quantitation was 4 ng/mL. Reproducibility at 10, 100 and 200 ng/mL concentration points of the standard curve gave coefficient variations of 6.1%, 7.8% and 1.6%, respectively. The recovery following solid phase extraction was 99.3% for DEC and 94.8% for the internal standard. This sensitive and specific analytical method is suitable for pharmacokinetic studies of DEC.

• Journal of Periodontal and Implant Science
• /
• 제52권1호
• /
• pp.28-38
• /
• 2022

Purpose: Macrophages play crucial roles as early responders to bacterial pathogens and promote/ or impede chronic inflammation in various tissues. Periodontal macrophage-induced pyroptosis results in physiological and pathological inflammatory responses. The transcription factor Dec2 is involved in regulating immune function and inflammatory processes. To characterize the potential unknown role of Dec2 in the innate immune system, we sought to elucidate the mechanism that may alleviate macrophage pyroptosis in periodontal inflammation. Methods: Porphyromonas gingivalis lipopolysaccharide (LPS) was used to induce pyroptosis in RAW 264.7 macrophages. Subsequently, we established an LPS-stimulated Dec2 overexpression cellular model in macrophages. Human chronic periodontitis tissues were employed to evaluate potential changes in inflammatory marker expression and pyroptosis. Finally, the effects of Dec2 deficiency on inflammation and pyroptosis were characterized in a P. gingivalis-treated experimental periodontitis Dec2-knockout mouse model. Results: Macrophages treated with LPS revealed significantly increased messenger RNA expression levels of Dec2 and interleukin (IL)-1β. Dec2 overexpression reduced IL-1β expression in macrophages treated with LPS. Overexpression of Dec2 also repressed the cleavage of gasdermin D (GSDMD), and the expression of caspase-11 was concurrently reduced in macrophages treated with LPS. Human chronic periodontitis tissues showed significantly higher gingival inflammation and pyroptosis-related protein expression than non-periodontitis tissues. In vivo, P. gingivalis-challenged mice exhibited a significant augmentation of F4/80, tumor necrosis factor-α, and IL-1β. Dec2 deficiency markedly induced GSDMD expression in the periodontal ligament of P. gingivalis-challenged mice. Conclusions: Our findings indicate that Dec2 deficiency exacerbated P. gingivalis LPS-induced periodontal inflammation and GSDMD-mediated pyroptosis. Collectively, our results present novel insights into the molecular functions of macrophage pyroptosis and document an unforeseen role of Dec2 in pyroptosis.

• BMB Reports
• /
• 제52권8호
• /
• pp.508-513
• /
• 2019

In this study, the anti-inflammatory effects of ${\alpha}-lipoic$ acid (LA) and decursinol (Dec) hybrid compound LA-Dec were evaluated and compared with its prodrugs, LA and Dec. LA-Dec dose-dependently inhibited lipopolysaccharide (LPS)-induced nitric oxide (NO) generation in BV2 mouse microglial cells. On the other hand, no or mild inhibitory effect was shown by the Dec and LA, respectively. LA-Dec demonstrated dose-dependent protection from activation-induced cell death in BV2 cells. LA-Dec, but not LA or Dec individually, inhibited LPS-induced increased expressions of induced NO synthase (iNOS) and cyclooxygenase-2 (COX-2) proteins in a dose-dependent manner in both BV2 and mouse macrophage, RAW264.7 cells. Furthermore, LA-Dec inhibited LPS-induced expressions of iNOS, COX-2, interleukin-6, tumor necrosis $factor-{\alpha}$, and $interleukin-1{\beta}$ mRNA in BV2 cells, whereas the same concentration of LA or Dec was ineffective. Signaling studies demonstrated that LA-Dec inhibited LPS-activated signal transducer and activator of transcription 3 and protein kinase B activation, but not nuclear factor-kappa B or mitogen-activated protein kinase signaling. The data implicate LA-Dec hybrid compound as a potential therapeutic agent for inflammatory diseases of the peripheral and central nervous systems.

• 청정기술
• /
• 제21권2호
• /
• pp.124-129
• /
• 2015

본 연구에서는 5~30 bar의 이산화탄소에 대한 DMPEG250 (dimethyl ether of polyethylene glycol), DEC (diethyl carbonate), DMC (dimethyl carbonate), 그리고 TAT (triacetin)의 용해도를 측정하기 위해 일정 부피법에 따른 용해도 측정 장치를 사용하였다. 이들에 대한 이산화탄소 용해도는 측정된 부피와 압력을 Peng-Robinson 방정식에 대입하여 얻은 이산화탄소의 몰수로부터 얻어졌다. 이산화탄소에 대한 물리 흡수제의 용해도는 같은 온도에 대해 DMPEG250 > TAT > DEC > DMC 순으로 나타났다. DMPEG250에 DEC를 혼합한 물리 흡수제를 사용할 경우 이산화탄소에 대한 용해도는 DMPEG250 단독에 의한 경우보다 높은 값을 가지는 것으로 확인되었다. 그러므로 DEC가 혼합된 DMPEG250/DEC 혼합 물리 흡수제는 기존의 DMPEG250이 가지는 높은 비용을 절감할 수 있을 뿐 아니라 용해도 향상까지 거둘 수 있어 향후 연소 후 이산화탄소 포집 공정에 효과적인 적용을 기대할 수 있다.

• Journal of Korean Neurosurgical Society
• /
• 제48권6호
• /
• pp.506-517
• /
• 2010

Objective : We investigated whether Disability Evaluation (DE) situations influence patients' neuropsychological test performances and psychopathological characteristics and which variable play a role to establish an explanation model using statistical analysis. Methods : Patients were 536 (56.6%) brain-injured persons who met inclusion and exclusion criteria, classified into the DE group (DE; n = 300, 56.0%) and the non-DE group (NDE; n = 236, 44.0%) according to the neuropsychological testing's purpose. Next, we classified DE subjects into DE cluster 1 (DEC1; 91, 17.0%), DE cluster 2 (DEC2; 125; 23.3%), and DE cluster 3 (DEC3; 84, 15.7%) via two-step cluster analysis, to specify DE characteristics. All patients completed the K-WAIS, K-MAS, K-BNT, SCL-90-R, and MMPI. Results : In comparisons between DE and NDE, the DE group showed lower intelligence quotients and more severe psychopathologic symptoms, as evaluated by the SCL-90-R and MMPI, than the NDE group did. When comparing the intelligence among the DE groups and NDE group, DEC1 group performed worst on intelligence and memory and had most severe psychopathologic symptoms than the NDE group did. The DEC2 group showed modest performance increase over the DEC1 and DEC3, similar to the NDE group. Paradoxically, the DEC3 group performed better than the NDE group did on all variables. Conclusion : The DE group showed minimal "faking bad" patterns. When we divided the DE group into three groups, the DEC1 group showed typical malingering patterns, the DEC2 group showed passive malingering patterns, and the DEC3 group suggested denial of symptoms and resistance to treatment.

• Nuclear Engineering and Technology
• /
• 제41권2호
• /
• pp.155-162
• /
• 2009

Since the 90's, EDF and AREVA-NP have irradiated, up to very high burnups, lead assemblies housing $M5^{(R)}$ cladded fuels. Post-irradiation examination of high burnup $UO_2$ pellets show an increase in the fission-gas release rate, an increase in fuel swelling, and formation of fission-gas bubbles throughout the pellets. Xenon abundances were quantified, and phenomena leading to this bubble formation were identified. All examinations provided valuable data on the complex state of the fuel during irradiation. They show the good behavior of these fuels, exhibiting various microstructures at very high burnups, none of which is likely to lead to problems during irradiation.

• 과학과기술
• /
• 제21권12호통권235호
• /
• pp.60-67
• /
• 1988

31년 전 창업한 디지틀 이큅먼트사(DEC)는 연간 매출고 1백억 달러에 이익 10억 달러를 올리는 컴퓨터계의 제2인자가 되었다. DEC는 IBM에 비해 규모는 6분의 1에 지나지 않지만 지난 20년대 이 '정보산업의 거인'IBM의 가장 두려운 도전자의 자리를 지켜왔다. 그래서 업계에서는 DEC를 골리앗IBM에 대항하는 '다윗'으로 비유하고 있다. DEC의 매출고는 1984년이래 중형 컴퓨터인 백스 미니컴퓨터의 큰 성공에 힘입어 불과 4년간에 2배로 급증했다. 대당 1만 5천 달러에서 70만 달러의 이 중형 컴퓨터시장에서 DEC의 시장점유율은 1984년의 19%에서 현재 25%으로 뛰어올랐으나 IBM은 24%에서 16%로 오히려 줄어들었다.

• 생명과학회지
• /
• 제28권11호
• /
• pp.1268-1276
• /
• 2018

Cytidine analog decitabine (DEC)은 핵산 합성의 억제제로서 골수이형성 증후군 및 급성 골수성 백혈병 치료제로 사용되고 있다. 산화질소 합성에서 번역 단계를 억제하는 것으로 알려진 ammonium pyrrolidine dithiocarbamate (PDTC)는 $NF-{\kappa}B$의 대표적인 억제제이다. 본 연구에서는 인체 위암 AGS 세포를 대상으로 DEC와 PDTC의 병용 처리에 따른 세포증식 억제 기전을 조사하였다. 본 연구의 결과에 따르면 PDTC에 의한 AGS 세포의 증식 억제 효과는 DEC에 의해 농도 의존적으로 유의하게 증가하였으며, 이는 G2/M기의 세포주기 정지 및 apoptosis 유도와 관련이 있었다. PDTC와 DEC의 병용 처리에 의한 세포 사멸의 유도는 DNA 손상 유도와 관련이 있음을 H2AX의 인산화 증가로 확인하였다. 아울러 PDTC와 DEC의 병용 처리는 미토콘드리아 막 전위의 파괴를 유도하고, 세포 내 활성산소종(ROS)의 생성과 Bax의 발현을 향상시키고, Bcl-2 발현을 감소시켰으며 미토콘드리아에서 세포질로의 cytochrome c 유출을 증가시켰다. 또한 PDTC과 DEC의 병용 처리는 외인성 및 내인성 apoptosis 개시 caspase에 해당하는 caspase-8과 caspase-9의 활성뿐만 아니라 caspase-3의 활성화와 PARP 단백질의 분해를 유도하였다. 결론적으로 본 연구의 결과는 PDTC와 DEC의 병용 처리가 DNA 손상을 유발하고, ROS 증가와 연계된 외인성 및 내인성 apoptosis 사멸 경로를 활성화시킴으로써 AGS 세포의 증식을 억제하였음을 의미한다.

• Journal of Preventive Medicine and Public Health
• /
• 제24권3호
• /
• pp.441-458
• /
• 1991

공무원 및 사립학교교직원 의료보험과 직장의료보험에서 입원, 외래별 수진을, 건당진료비 (1985년 기준 불변가격), 건당진료일수 등의 장래예측을 통해 의료보험 진료비 안정화 방안을 마련하는데 기초자료로 제시하기 위하여, 이들의 $1979{\sim}89$년간 월별 통계자료를 이용, Box-Jenkins model인 ARIMA 모델을 적용하여 1994년 까지의 수진을, 건당진료비 및 건당진료일수를 예측한 결과를 요약하면 다음과 같다. 수진을, 건당진료비 및 건당진료일수의 ARIMA 모형을 제시하면 다음 표와 같다. 상기의 ARIMA 모형을 기초로하여 향후 5년간의 수진율을 예측한 결과, 공교의료보험 입원의 경우, 1989년의 실측치는 0.068건 이었으며, 1990년과 1991년은 0.068건, 1992년과 1993년은 0.069건, 1994년은 0.070건으로 연평균 0.7%정도 증가될 것으로 예측되었으며, 외래의 경우, 1989년의 실측치는 3.487건이었으나 1990년은 3.530건, 1994년은 3.668건으로 연평균 1%정도 증가될 것으로 예측되었다. 직장의료보험 입원의 경우, 1989년의 실측치는 0.063건이었으며, 1990년부터 1994년까지 모두 0.063건으로 안정될 것으로 예측되었으며, 외래의 경우 1989년의 실측치는 2.984건이었으나, 1990년은 3.016건, 1994년은 3.154건으로 연평균 1.1% 정도 증가될 것으로 예측되었다. 건당진료비의 향후 예측치는 12월을 기준으로하여 1985년 불변가격으로 공교의료보험 입원의 경우, 1989년의 실측치는 332,751원이었으나, 1990년은 345,938원, 1994년은 354,511원으로 연평균 0.6%정도 증가될 것으로 예측되었으며, 외래의 경우, 1989년의 실측치는 11,925원이었으나, 1990년은 12,638원, 1994년은 12,904원으로 연평균 0.5%정도 증가될 것으로 예측되었다. 직장의료보험 입원의 경우, 1989년 실측치는 281,835원이었으나, 1990년은 282,524원, 1994년은 293,973원으로 연평균 1%정도 증가될 것으로 예측되었으며, 외래의 경우, 1989년 실측치는 11,599원이었으나, 1990년부터 1994년까지 11,585원으로 안정될 것으로 예측되었다. 건당진료일수의 향후 예측치는 12월을 기준으로 하여 공교의료보험 입원의 경우, 1989년의 실측치는 13.79일이었으며, 1990년은 13.82일, 1993년과 1994년은 13.85일로 거의 안정될 것으로 예측되었으며, 외래의 경우, 1994년까지 5일 정도로 안정될 것으로 예측되었다. 직장의료보험 입원의 경우, 1989년의 실측치는 12.23일이었으나, 1990년은 12.30일, 1994년은 12.85일로 연평균 1.1%정도 증가될 것으로 예측되었으며, 외래의 경우 1989년의 실측치는 4.61일이었으며 1990년부터 1994년까지 4.60일로 안정될 것으로 예측되었다.

• 한국수정란이식학회지
• /
• 제26권3호
• /
• pp.153-158
• /
• 2011

This study was performed in order to simplify the operation and minimize stress of donor and be readily available in the field with low cost and high quality embryos using the Direct Embryo Collection (DEC). Donors, at random stages of the estrous cycle, received a CIDR. 7 days later, 200 mg FSH was treated with 40, 30, 20, 10 mg FSH levels in declining doses twice daily by intramuscular injection for 4 days. On the 3rd day administration of FSH, 25 mg $PGF_2{\alpha}$ was administered and CIDR was withdrawn. After FSH injections were complete, donors were artificially inseminated twice at 12 hr intervals. The donor cattle received 250 ${\mu}g$ GnRH at time of 1 st insemination and embryos were recovered 8 days after the 1st insemination. Embryo collection from superovulated donors was performed to flushing by non-surgical methods of 3-way, 2-way and DEC (l-way). The average number of recovered embryos were 11.25${\pm}$0.63, 12.5${\pm}$0.65 and 11.75${\pm}$0.48 from operations of 3-way, 2-way and DEC methods, respectively. There were no significant differences among the embryo collection methods. Also, The average number of transferable embryos were 6.25${\pm}$0.48, 7.25${\pm}$0.48 and 7.25${\pm}$0.63 from each embryo collection procedures. The number of transferable embryos was no differences among the 3-way, 2-way and DEC methods, respectively. Meanwhile, the ratio of transferable embryos for all recovered embryos from DEC methods was higher as 61.7 % than 55.6 %, 58 % from methods of 3-way, 2-way. And the flushing solution required for recovering embryos by DEC method was significantly lower as 0.28${\pm}$0.32 1 than 1.8${\pm}$0.12 1, 1.75${\pm}$0.10 1 from 3-way, 2-way methods (p<0.05). Also, the time required for recovering embryos by DEC methods was significantly lower as 27${\pm}$2 min than 51${\pm}$3, 45${\pm}$2 min, respectively (p<0.05). In conclusion, these results suggest that DEC method for embryo collection may be effectively used for production of in vivo embryos using less flushing solution and, it might be effectively available in the field compared to conventional embryo recovery methods using 3-way or 2-way balloon catheter.